Roundup® (Glyphosate) Settlement: Case Management & Litigation Documents
Randall King, et al. v. Monsanto Company | No. 2622-CC00325
The 22nd Judicial Circuit Court in the City of St. Louis, Missouri, is overseeing the proposed $7.25 billion class action settlement regarding Roundup® and glyphosate-based herbicides. This centralized repository contains the official Case Management Orders (CMOs), settlement exhibits, and legal notices required for claimants and legal representatives.
Note to Counsel: All deadlines are strictly enforced by the Court. Failure to register or object by the specified dates may result in a permanent waiver of rights.
Case Management Orders & Official Litigation Documents
These documents have been electronically filed in the 22nd Judicial Circuit Court, City of St. Louis, Missouri.
Recent Filings (2026)
- 02/17/2026: [Official Exhibit: List of NHL Subtypes]
Detailed classification used by the Special Master to assign Aggressive or Indolent status to diagnoses for tier-based compensation. - 02/17/2026: [Official Exhibit A: Roundup® Products List]
The exhaustive directory of all EPA-registered glyphosate products covered by the settlement, including consumer, professional, and agricultural brands. - 02/17/2026: [Court-Authorized Settlement Notice]
The primary notice informing potential class members of their rights, including the $7.25 billion settlement fund and payout ranges.
Critical Litigation Deadlines
Based on the current CMOs and the Settlement Agreement, please note the following strictly enforced dates:
- 02/13/2026: Cutoff for Initial Claimants
Deadline for individuals to have already filed a lawsuit or signed a tolling agreement to qualify for specific expedited award categories. - 05/07/2026: Deadline for Attorneys’ Fees Application
The date by which Class Counsel must submit their motion for fees and service awards to the Court. - 06/04/2026: Deadline for Exclusion (Opt-Out) Requests
Requests must be postmarked or electronically submitted by this date to preserve the right to sue for compensatory damages outside the settlement. - 06/04/2026: Deadline for Filing Written Objections
The final date to file a formal objection to any part of the proposed settlement or fee request with the Court. - 07/09/2026: Final Fairness Hearing (9:00 a.m. CT)
The scheduled hearing at the Civil Courts Building in St. Louis to determine if the settlement is fair, reasonable, and adequate.
Claims & Award Determination
The settlement utilizes a rigorous scoring system to distribute awards ranging from $6,000 to over $165,000.
NHL Subtype Classifications
Per the filed Exhibit, the Allocation Special Master categorizes diagnoses as follows:
- Aggressive NHL: Includes Diffuse Large B-Cell Lymphoma (DLBCL), Burkitt Lymphoma, and Mantle Cell Lymphoma.
- Indolent NHL: Includes Follicular Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Hairy Cell Leukemia.
The Scoring System
Awards are adjusted based on the following Claim Score factors:
- Invasiveness of Treatment: Higher scores for chemotherapy, radiation, or transplants.
- Strength of Proof: Documentation such as receipts or photos increases the score.
- Medical History: Adjustments for prior blood disorders or immunosuppressant use.
Resource Center for Counsel & Clients
For real-time updates regarding settlement eligibility, document filing, and Case Management Orders, please utilize the following Nigh Goldenberg Raso & Vaughn resources:
- NGRV Case Management: Our dedicated team is available to assist both individual claimants and co-counsel with the complex registration and documentation requirements of this $7.25 billion settlement.
- Document Access: To review the full List of NHL Subtypes or Exhibit A (Product List), contact our Minneapolis Headquarters directly.
- Legal Guidance: If you are unsure whether you qualify as an Occupational or Residential claimant, our attorneys can provide a comprehensive review of your exposure history.
Start Your Recovery Today
The deadlines for the Randall King v. Monsanto settlement are strictly enforced by the Court. Do not let an insurance company or a predatory platform dictate the value of your future.
Contact NGRV’s National Intake Center for a free, confidential case evaluation:
- Phone: (612) 642-2922
- Online: Please use the Secure Contact Form located on the right side of this page to submit your inquiry directly to our legal team.
